Here are the bills that are currently being considered by California legislators.
To support or oppose a certain bill, contact the original sponsors of the bill and your local representatives, to tell them your opinions.
| Session | Bill Number | Document | Key Issue | Bill Name | Sponsored By | Contact Sponsor | 
|---|---|---|---|---|---|---|
| 2025-2026 Regular Session | SB378 | DETAILS | Enforces reporting, liability, and disclosure requirements on online cannabis and hemp marketplaces to curb unlicensed sales, enhance consumer safety, and impose strict penalties for facilitating illegal transactions, especially those harming children. | Online marketplaces: illicit cannabis: reporting and liability | Scott Wiener (D) | Scott Wiener | 
| 2025-2026 Regular Session | AB564 | DETAILS | The bill repeals the scheduled cannabis excise tax adjustments, keeping the rate at 15% and preventing future increases | Cannabis: excise tax: rate increase repeal | Matt Haney (D) | Matt Haney | 
| 2025-2026 Regular Session | AB8 | DETAILS | This act revises numerous provisions of California’s Business and Professions Code, Health and Safety Code, and Revenue and Taxation Code to update definitions, regulations, and taxes related to cannabinoids, while adding new sections, repealing outdated ones, and appropriating funds for implementation. | Cannabis: cannabinoids: industrial hemp. | Cecilia Aguiar-Curry (D) | Cecilia Aguiar-Curry | 
| 2025–2026 Regular Session | AB1103 | DETAILS | The bill streamlines California’s controlled substances research process by empowering the Research Advisory Panel to fast-track certain federally approved studies, delegate reviews to subgroups, maintain confidentiality, withdraw approvals with notice, and extend closed-session authority through 2028 while requiring annual reports to state leaders. | Controlled substances: research | Chris Ward (D) | Chris Ward | 
| 2025–2026 Regular Session | AB1332 | DETAILS | Allows licensed microbusinesses with M-licenses to ship certain medicinal cannabis products directly to severely ill patients under strict safeguards until 2029, aiming to improve access for about 4,000 Californians who struggle to obtain specialized treatments through local dispensaries. | Medicinal cannabis: shipments | Patrick Ahrens (D) | Patrick Ahrens |